Cargando…
Newborn Screening for SCID Identifies Patients with Ataxia Telangiectasia
PURPOSE: Severe combined immunodeficiency (SCID) is characterized by failure of T lymphocyte development and absent or very low T cell receptor excision circles (TRECs), DNA byproducts of T cell maturation. Newborn screening for TRECs to identify SCID is now performed in several states using PCR of...
Autores principales: | Mallott, Jacob, Kwan, Antonia, Church, Joseph, Gonzalez-Espinosa, Diana, Lorey, Fred, Tang, Ling Fung, Sunderam, Uma, Rana, Sadhna, Srinivasan, Rajgopal, Brenner, Steven E., Puck, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591536/ https://www.ncbi.nlm.nih.gov/pubmed/23264026 http://dx.doi.org/10.1007/s10875-012-9846-1 |
Ejemplares similares
-
Nijmegen Breakage Syndrome Detected by Newborn Screening for T Cell Receptor Excision Circles (TRECs)
por: Patel, Jay P., et al.
Publicado: (2015) -
Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia
por: Blom, Maartje, et al.
Publicado: (2019) -
Establishing Newborn Screening for SCID in the USA; Experience in California †
por: Puck, Jennifer M., et al.
Publicado: (2021) -
Combined Immunodeficiency Due to MALT1 Mutations, Treated by Hematopoietic Cell Transplantation
por: Punwani, Divya, et al.
Publicado: (2015) -
Genomic Analysis of Historical Cases with Positive Newborn Screens for Short-Chain Acyl-CoA Dehydrogenase Deficiency Shows That a Validated Second-Tier Biochemical Test Can Replace Future Sequencing
por: Adhikari, Aashish N., et al.
Publicado: (2020)